Translation and validation of the Persian version of the Stroke Self-Efficacy Questionnaire in stroke survivors.

IF 1.7 4区医学 Q4 NEUROSCIENCES International Journal of Neuroscience Pub Date : 2024-11-01 Epub Date: 2023-10-26 DOI:10.1080/00207454.2023.2273776

Alia Saberi, Sajjad Saadat, Fatemeh Dadar, Mozaffar Hosseininezhad, Kasra Sarlak, Samaneh Ghorbani Shirkouhi, Nasim Athari, Nima Broomand Lomer

{"title":"Translation and validation of the Persian version of the Stroke Self-Efficacy Questionnaire in stroke survivors.","authors":"Alia Saberi, Sajjad Saadat, Fatemeh Dadar, Mozaffar Hosseininezhad, Kasra Sarlak, Samaneh Ghorbani Shirkouhi, Nasim Athari, Nima Broomand Lomer","doi":"10.1080/00207454.2023.2273776","DOIUrl":null,"url":null,"abstract":"Background: The Stroke Self-Efficacy Questionnaire (SSEQ) is a self-report scale that measures stroke survivors' self-efficacy and covers specific domains of functioning after stroke.Objectives: We aimed to determine the validity and reliability of the Persian version of the SSEQ.Methods: This descriptive cross-sectional study included 124 stroke patients in the sub-acute phase (between 2 weeks and 3 months of stroke onset). The original SSEQ was translated to Persian and back-translated to English. Demographic, neurologic examination, 'Persian Stroke Self-Efficacy Questionnaire (SSEQ-P)', and 'General Self-Efficacy Scale' (GSE-10) data were collected. The reliability of the questionnaire was evaluated by test-retest assessment among 30 people with stroke at an interval of two weeks. Factor analysis was used to assess the validity of SSEQ-P. Cronbach's alpha assessed internal consistency in all participants. Statistical analysis was performed by SPSS software version 23 and SmartPLS version 3.Results: In this study, the mean of SSEQ scores was 87.99 ± 37.09. Content Validity Ratio (CVR) and Content Validity Index (CVI) were favorable. Convergent validity of the questionnaire was reported (r = 0.669) using GSE. Factor loadings of items in SSEQ ranged from 0.41 to 0.92. Validity indices (AVE = 0.75, SRMR = 0.07) showed that the single-factor model of the present study owns a favorable fit. Test-retest reliability and Cronbach's alpha values of SSEQ in the present study were calculated at 0.80 and 0.97, respectively.Conclusions: The Persian version of the SSEQ depicted acceptable reliability and validity and can be utilized to evaluate the self-efficacy of patients with stroke.HIGHLIGHTSStroke Self-Efficacy Questionnaire (SSEQ) is a self-report scale that measures stroke survivors' self-efficacy.The Persian version of the SSEQ demonstrated acceptable reliability and validity and can be used in stroke patients.","PeriodicalId":14161,"journal":{"name":"International Journal of Neuroscience","volume":" ","pages":"1365-1371"},"PeriodicalIF":1.7000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00207454.2023.2273776","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The Stroke Self-Efficacy Questionnaire (SSEQ) is a self-report scale that measures stroke survivors' self-efficacy and covers specific domains of functioning after stroke.

Objectives: We aimed to determine the validity and reliability of the Persian version of the SSEQ.

Methods: This descriptive cross-sectional study included 124 stroke patients in the sub-acute phase (between 2 weeks and 3 months of stroke onset). The original SSEQ was translated to Persian and back-translated to English. Demographic, neurologic examination, 'Persian Stroke Self-Efficacy Questionnaire (SSEQ-P)', and 'General Self-Efficacy Scale' (GSE-10) data were collected. The reliability of the questionnaire was evaluated by test-retest assessment among 30 people with stroke at an interval of two weeks. Factor analysis was used to assess the validity of SSEQ-P. Cronbach's alpha assessed internal consistency in all participants. Statistical analysis was performed by SPSS software version 23 and SmartPLS version 3.

Results: In this study, the mean of SSEQ scores was 87.99 ± 37.09. Content Validity Ratio (CVR) and Content Validity Index (CVI) were favorable. Convergent validity of the questionnaire was reported (r = 0.669) using GSE. Factor loadings of items in SSEQ ranged from 0.41 to 0.92. Validity indices (AVE = 0.75, SRMR = 0.07) showed that the single-factor model of the present study owns a favorable fit. Test-retest reliability and Cronbach's alpha values of SSEQ in the present study were calculated at 0.80 and 0.97, respectively.

Conclusions: The Persian version of the SSEQ depicted acceptable reliability and validity and can be utilized to evaluate the self-efficacy of patients with stroke.HIGHLIGHTSStroke Self-Efficacy Questionnaire (SSEQ) is a self-report scale that measures stroke survivors' self-efficacy.The Persian version of the SSEQ demonstrated acceptable reliability and validity and can be used in stroke patients.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

脑卒中幸存者脑卒中自我效能问卷波斯语版的翻译和验证。

背景：卒中自我效能问卷（SSEQ）是一种自我报告量表，用于衡量卒中幸存者的自我效能，涵盖卒中后功能的特定领域。目的：我们旨在确定波斯版SSEQ的有效性和可靠性。方法：这项描述性横断面研究包括124名处于亚急性期（中风发作2周至3个月之间）的中风患者。最初的SSEQ被翻译成波斯语，并被重新翻译成英语。收集人口学、神经系统检查、“波斯卒中自我效能问卷（SSEQ-P）”和“一般自我效能量表”（GSE-10）数据。问卷的可靠性是通过对30名中风患者的重新测试评估来评估的，间隔两周。因子分析用于评估SSEQ-P的有效性。Cronbachα评估了所有参与者的内部一致性。采用SPSS软件23版和SmartPLS软件3版进行统计分析。结果：本研究SSEQ得分平均值为87.99 ± 37.09.内容有效率（CVR）和内容有效指数（CVI）良好。报告了问卷的收敛有效性（r = 0.669）。SSEQ中项目的系数荷载范围为0.41至0.92。有效性指数（AVE=0.75，SRMR=0.07）表明，本研究的单因素模型具有良好的拟合性。本研究中SSEQ的测试-再测试可靠性和Cronbachα值分别计算为0.80和0.97。结论：波斯版SSEQ描述了可接受的信度和有效性，可用于评估中风患者的自我效能。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

International Journal of Neuroscience 医学-神经科学

CiteScore

5.10

自引率

0.00%

发文量

132

审稿时长

2 months

期刊介绍： The International Journal of Neuroscience publishes original research articles, reviews, brief scientific reports, case studies, letters to the editor and book reviews concerned with problems of the nervous system and related clinical studies, epidemiology, neuropathology, medical and surgical treatment options and outcomes, neuropsychology and other topics related to the research and care of persons with neurologic disorders. The focus of the journal is clinical and transitional research. Topics covered include but are not limited to: ALS, ataxia, autism, brain tumors, child neurology, demyelinating diseases, epilepsy, genetics, headache, lysosomal storage disease, mitochondrial dysfunction, movement disorders, multiple sclerosis, myopathy, neurodegenerative diseases, neuromuscular disorders, neuropharmacology, neuropsychiatry, neuropsychology, pain, sleep disorders, stroke, and other areas related to the neurosciences.